Tag: bahn

Quick Search


Active Surveillance with High Resolution Color-Doppler Transrectal Ultrasound Monitoring: Is it Foolproof?

Wed 28 Feb 2007

  Edited from PCRI Insights February 2007, vol. 10, no. 1 Duke Bahn, MD, Prostate Institute of America, Ventura, CA Mark Scholz, MD and Richard Lam, MD Prostate Oncology Specialists, Marina Del Rey, CA To embark on Active Surveillance is not to forgo radical local treatment altogether. Rather it is to delay therapy as longRead More ›

Cancer Cryo-Immunotherapy: A Battle Between the Immune System and Cancer

Wed 1 Feb 2006

Haakon Ragde, MD The Haakon Ragde Foundation for Advanced Cancer Studies, Seattle, WA and Duke K. Bahn, MD The Prostate Institute of America of Community Memorial Hospital, Ventura, CA PCRI Insights February 2006 vol. 9, no. 1 As most of us know, the immune system plays a critical role in controlling and eliminating infectious organisms,Read More ›

Cryoablation of the Prostate

Tue 1 Feb 2005

PCRI Insights February 2005 vol. 8, no. 1 Duke K. Bahn, MD and Paul Silverman, MD Prostate Institute of America at Community Memorial Hospital,Ventura, CA John C. Rewcastle, PhD Department of Radiology, University of Calgary, Canada and Endocare, Inc., Irvine, CA CRYOABLATION, OR FREEZING, OF THE PROSTATE WAS FIRST INTRODUCED IN THE 1960s FOLLOWING THERead More ›

Color Doppler and Tissue Harmonic Ultrasound in the Early Detection and Staging of Prostate Cancer

Fri 1 Nov 2002

Duke K. Bahn, M.D., Prostate Institute of America Reprinted from PCRI Insights November 2002 v5.2   Transrectal ultrasound (TRUS) imaging has long been an essential tool for prostate cancer (PC) diagnosis. In fact, the combination of prostate specific antigen (PSA) testing with TRUS and digital rectal examination (DRE) has been responsible for diagnosing most prostateRead More ›